1. Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity?. Issue 5 (4th May 2021) Authors: Acikgoz, Yusuf; Bal, Oznur; Ucar, Gokhan; Durnali, Ayse; Ergun, Yakup; Dirikoc, Merve; Esen, Selin Akturk; Dogan, Mutlu Journal: Expert opinion on drug safety Issue: Volume 20:Issue 5(2021) Page Start: 611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer. (2nd December 2019) Authors: Ergun, Yakup; Acikgoz, Yusuf; Bal, Oznur; Ucar, Gokhan; Dirikoc, Merve; Caliskan Yildirim, Eda; Akdeniz, Nadiye; Uncu, Dogan Journal: Expert review of molecular diagnostics Issue: Volume 19:Number 12(2019) Page Start: 1131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer. Issue 39 (25th September 2020) Authors: Ucar, Gokhan; Ergun, Yakup; Aktürk Esen, Selin; Acikgoz, Yusuf; Dirikoc, Merve; Esen, İrfan; Bal, Öznur; Uncu, Doğan Other Names: Kok. Victor C. section editor. Journal: Medicine Issue: Volume 99:Issue 39(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer. Issue 48 (25th November 2020) Authors: Açikgoz, Yusuf; Gurler, Fatih; Inci, Bediz Kurt; Ergun, Yakup; Ucar, Gokhan; Dirikoc, Merve; Esen, Selin Akturk; Tekin, Berna Okudan; Bal, Oznur; Dogan, Mutlu; Uncu, Dogan Other Names: Li. Jie section editor. Journal: Medicine Issue: Volume 99:Issue 48(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗